Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Patent
1998-05-22
1999-10-19
Geist, Gary
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
5142378, 514393, 514412, 514471, 514533, 514535, 5483027, 548516, 549496, 560 24, 560 46, 560 47, C07D26530, C07D23502, C07Z26100, C07Z22960
Patent
active
059691336
ABSTRACT:
A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive moiety.
REFERENCES:
patent: 5571845 (1996-11-01), Denny et al.
patent: 5602278 (1997-02-01), Kirkpatrick
Beall et al., "Metabolism of Bioreductive Antitumor Compounds by Purified Rat and Human DT-Diaphorases", Cancer Research 54:3196-3201, 1994.
Garzon-Aburbeh et al., "1,3-Dipalmitoylglycerol Ester of Chlorambucil as a Lymphotropic, Orally Administrable Antineoplastic Agent" J. Med. Chem. 26:1200-1203, 1983.
Lin et al., "Potential Bioreductive Alkylating Agents. 5. Antineoplastic Activity of Quinoline-5,8-diones, Naphthazarins and Naphthoquinones" J. Med. Chem. 18:917-921, 1975.
Lin et al., "Potential Bioreductive Alkylating Agents. 3. Synthesis and Antineoplastic Activity of Acetoxymethyl and Corresponding Ethyl Carbamate Derivatives of Benzoquinones" J. Med. Chem. 7:558-561, 1974.
Lin et al., "Potential Bioreductive Alkylating Agents. 2. Antitumor Effect and Biochemical Studies of Naphthoquinone Derivatives" J. Med. Chem. 16:1268-1271, 1973.
Lin et al., "Potential Bioreductive Alkylating Agents. 1. Benzoquinone Derivatives" J. Med. Chem. 15:1247-1252, 1972.
O'Brien et al., "Differential Cytotoxicity of Diaziquone toward Chinese Hamster Ovary Cells Under Hypoxic and Aerobic Exposure Conditions" Cancer Research 50:1516-1520, 1990.
Oostveen et al., "Mitomycin Analogs I. Indologuinones as (Potential) Bisalkylating Agents" Tetrahedron 43:255-262, 1987.
O'Shea et al., "Pulse Radiolytic Kinetic Study of the Decay of .alpha.-Methyl-Substituted Benzoquinone Radical Anions: A Possible Mechanistic Model for Bioreductive Alkylation" J. Am. Chem. Soc. 113:611-615, 1991.
Wilson et al., "Hypoxia-Selective Antitumor Agents. 2. Electronic Effects of 4-Substituents on the Mechanisms of Cytotoxicity and Metabolic Stability of Nitracrine Derivatives" J. Med. Chem. 32:31-38, 1989.
Wilson et al., "Hypoxia-Selective AntiFumor Agents. 1. Relationships Between Structure, Bedox Properties and Hypoxia-Selective Cyctoxicity for 4-Substituted Derivatives of Nitracrine" J. Med. Chem. 32:23-30, 1989.
Database CAPLUS on STN, Acc. No. 1983:594554, Witiak et al., `Bis(bioreductive) alkylating agents: synthesis and biological activity in a nude mouse human carcinoma model.` J. Med. Chem. (1983), 26(12), 1679-86. (abstract).
Dales Natalie
Holden Sylvia
Koya Keizo
Ono Mitsunori
Sun Lijun
Davis Brian J.
Geist Gary
Shiongi BioResearch Corp.
LandOfFree
Bioreductive cytotoxic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioreductive cytotoxic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioreductive cytotoxic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057088